基于(关键地区、市场参与者、规模和份额)的电池扩展市场 - 到 2031 年的预测

  • Report Code : TIPRE00006576
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 202
Buy Now

市场洞察

细胞扩增是一项有效的技术,可应用于多个生物制品领域,特别是研发和疾病治疗。全球电池扩产市场预计将达到428.3711万美元­ 2018 年为 11,929.43 百万美元,预计到 2027 年该市场将以 15.6% 的复合年增长率增长­­­­­­–2027 年。

组织工程是最近已有四分之一个世纪的历史。尽管还处于起步阶段,但该技术的卓越地位却像野火一样蔓延开来。它很快就进入了再生医学领域,并成为对抗多种慢性疾病的最有力的防御手段。事实证明,从治愈受伤的组织到受损的器官,它在各个领域都有效。虽然他们在移植和疾病治疗中发现了最大的利用,但该技术在研发以及医疗保健的各个领域都有重要的应用。细胞扩增和再生医学技术已迅速进入药物开发、药物筛选、疫苗开发、细胞微生物学研究以及迄今为止被认为无法治疗的疾病(例如类风湿性关节炎和糖尿病)的治疗领域。自动化系统减少了对熟练劳动力的需求和持续的成本。慢性病发病率的增长是推动全球细胞扩增市场增长的关键因素。这与政府对细胞研究的关注和投资的增加以及对未来趋势的细胞技术的日益关注

未来趋势

随着传染病的惊人增加密切相关对于疾病和癌症患者来说,当前需要的是找到立即的解决方案,以尽量减少其负面影响。这些疾病在全球范围内不断出现,为细胞扩增市场的增长创造了诱人的机会。可以探索的另一种选择是药物发现,但所需的时间投入和这些药物成功的可能性不大,这给全球细胞扩增市场带来了优势,吸引了市场参与者的大量投资。

驱动因素< /h3>

越来越多地采用再生医学

再生医学具有替代或治愈组织甚至受损器官的潜力。再生技术用于发育组织,包括细胞扩增程序。它有助于研究伤害和疾病的潜在治疗方法。这些疾病可能是任何疾病,从骨折到神经退行性疾病。当我们开始了解使用如此先进的科学应用所带来的可能性时,再生医学的采用明显增加。这是全球细胞扩增市场不断增长的前厅。该技术可以灵活地使用各种类型的干细胞,例如成体、胚胎和诱导多能细胞。制药公司开发的新药可以使用分化的干细胞进行安全有效的测试。此外,使用基于细胞的模型的再生医学有可能帮助研究人员进行早期干预治疗。细胞扩增技术在医学和研究中的巨大潜力预计将推动全球细胞扩增市场的增长。

癌症患病率上升

癌症是人类罹患癌症的主要原因之一全世界的死亡。即使一个人不会因讽刺而面临迫在眉睫的死亡,他们仍然必须应对它所带来的情感和身体创伤。这种人的总体生活质量大大下降。这种情况最具破坏性的方面是我们未能治愈这种情况。然而,再生医学和基于细胞的方法学已经带来了一股新鲜空气。细胞扩增和再生医学的道路已经开辟了一条道路,可能会引导我们减轻这种疾病对我们社区的影响。由于生活方式的原因,癌症患者的患病率不断增加,导致他们比以往任何时候都更多地接触致癌因素。此外,预期寿命的延长会增加患癌症的风险,并导致对细胞疗法的需求增加。这就像全球细胞扩增市场增长的加速器。

限制

细胞扩增过程中的污染风险

尽管细胞培养在生物和医学领域发挥着至关重要的作用研究表明,已有足够的证据表明细胞培养物经常被微生物或其他细胞污染。这阻碍了研究活动,其中药物最初是在肿瘤细胞系上进行测试的。此外,获得了一些不可靠的结果,导致有效治疗的延误。此外,据观察,在处理不同的细胞培养物时多次使用移液器可能会导致交叉污染。如果受污染的细胞比原始细胞繁殖得更快,它们就能迅速主导群体,改变培养物的特性。此类事件通常未被检测到,因为来自不同来源的细胞也可能在形态上相似。细胞可能会经历染色体复制或重排、突变和表观遗传变化,从而改变其表型。

战略见解

市场细分

按产品

< h3>再生医学研究活动奠定细分市场主导地位

从产品角度来看,全球细胞扩增市场分为耗材和仪器,其中耗材细分市场在2018年占据主导地位,规模最大收入份额,预计在预测期内复合年增长率最高。研究过程中使用的实验室消耗品测量、分析和验证元素的未经证实的数量、性质和特征。由于再生和个性化医学研究的不断发展,该细分市场预计将保持其主导地位。

仪器细分市场包括离心机、细胞计数器、流式细胞仪和自动细胞扩增系统。细胞扩增支持仪器在扩增过程中提供无菌环境。工业规模的生物反应器利用可重复性来实现稳定的干细胞增殖。市场参与者的技术进步和产品发布预计将推动预测期内的细分市场增长。

全球电池扩展市场(按产品) - 2018年和2027年

按应用划分

干细胞研究应用的增加刺激细分市场的增长

根据应用,细胞扩增市场领域分为再生医学和干细胞研究、癌症和细胞研究以及其他应用。 2018年,再生医学和干细胞研究领域占据最大的市场份额。此外,它可能在预测期内快速增长。再生医学涉及复活和替换死亡或受损组织的现代方法和研究。干细胞对于再生医学研究至关重要,在发育生物学中有许多潜在的应用。因此,国际上采取了各种举措来增加干细胞在再生医学中的使用。英国和日本在干细胞和再生医学研究方面处于世界领先地位。

癌症和细胞研究领域是 2018 年全球细胞扩增市场的第二大占有者。癌症治疗一直是多个全球组织的研究导向。世界范围内的研究已经确定使用干细胞治疗小细胞肺癌(SCLC),这是一种仅在吸烟者中发现的重要致癌形式。预计此类发展将在预测期内以指数方式推动细分市场需求。

区域洞察

从地理位置上看,全球电池扩张市场包括北美、欧洲、亚太地区 (APAC)、中东及非洲 (MEA) 和南美洲中美洲 (SCAM)。

北美以最大的业务份额和占有率主导了 2018 年的电池扩容市场。区域市场的增长归因于慢性和先天性疾病患病率的上升以及研究资金的可获得性。美国、加拿大和墨西哥是该地区的主要市场,由于研究和持续开发而发生了连续的变化。美国采取了多项举措致力于将干细胞用于治疗目的。加拿大拥有干细胞网络 (SCN),这是一个由政府支持的全国性非营利组织,致力于再生医学研究并在全国范围内提供培训。

亚太细胞扩增市场预计将随着整个预测期内复合年增长率最高。老年人口的增加和慢性病患病率的增加是促进细胞扩增区域市场增长的关键参数。由于各自医疗保健行业的发展,亚太地区的一些国家在细胞扩增市场中经历了增长机会。在中国,干细胞用于治疗多种疾病并取得了新的显着进展。中国科学院(CAS)启动了三个治疗严重眼科和妇科疾病的干细胞研究计划。印度生物技术部(DBT)自2001年以来一直积极投资基础干细胞研究,已有40多家研究所和医院参与研究活动。

全球细胞扩增市场利润丰厚的地区

主要市场参与者

  • BD(美国)
  • Merck KGaA(德国)
  • Thermo Fisher Scientific , Inc(美国)
  • Terumo Corporation(日本)
  • 通用电气公司(美国)
  • 康宁公司(美国)
  • Miltenyi Biotec(美国)
  • Danaher(美国)
  • Lonza(瑞士)
  • Stemcell Technologies, Inc(加拿大)

主要进展

  • 2019 年 3 月:BD 推出了 BD FACSDuet,一种新型自动流式细胞术样品制备仪器。获得Conformité认证Européene (CE) - 体外诊断 (IVD)。
  • 2019 年 10 月:默克收购了 FloDesign Sonics,这是一家独特的声学细胞处理平台开发商,适用于细胞和基因治疗制造的工业化.
  • 2019年6月:赛默飞世尔科技推出用于细胞培养的Cytomat 2 C-LiN系列自动培养箱。该仪器具有受控的自动湿度和内置污染减少系统。
  • 2019 年 12 月:GE Healthcare Life Sciences 推出了用于细胞治疗工作流程的 SpinOculation C-Pro 协议软件。

报告范围

全球细胞扩增市场研究报告从规模、份额、趋势和预测方面提供了对再生医学和细胞培养的详细见解。它提供了关于驱动因素、限制因素、机会、细分市场和产业格局的清晰而准确的专业知识。全球和区域市场洞察提供当前和未来的行业场景,以确定投资决策。一些主要市场参与者及其近年来各自的发展已被保留为特别提及。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is cell expansion?

Cell expansion is the large scale artificial production of daughter cells from a single cell, to support medical research. The process of cell expansion plays a critical role in enhancing the benefits and uses of fully differentiated as well as stem cell cultures for their use in therapeutics, drug screening tools or advanced research purposes.

What are the restraining factor for cell expansion market?

Risk contamination during the cell expansion is expected to hinder the growth of cell expansion market. Despite of the important role of cell culture and development in the study of biology and medicine, enough evidences have been accumulated that the cell cultures are frequently contaminated or misidentified by microorganisms or other cells. This may lead to substantial problems in various fields such as cancer research, wherein drugs are initially tested with cell line derived from the targeted type of tumor. This may lead to unreliable results delaying discovery of effective treatments.

The List of Companies in Global Cell Expansion Market

  1. BD
  2. Merck KGaA
  3. Thermo Fisher Scientific, Inc.
  4. Terumo Corporation
  5. General Electric Company
  6. Corning Incorporated
  7. Miltenyi Biotec
  8. Danaher
  9. Lonza
  10. STEMCELL TECHNOLOGIES, INC.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports